Elena Ridloff, Director of Kymera Therapeutics KYMR, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $1.3M. The latest trade was on 06/24.

ER

ER

Elena Ridloff

Director

Company

Kymera Therapeutics KYMR

First filing

23/06/20

Trades

41 trades

Buys / sales

0 / 14

12-month net buying

−$1.3M

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	05/11	05/11	3,000 sh	$87.00	$261,000	−100.0%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	03/31–04/01	04/01	12,000 sh3 trades	$85.39avg.	$1,024,644	−100.0%
Sionna TherapeuticsSION	Open-market sale10b5-1 plan	25/08/29–25/09/02	25/09/03	9,584 sh2 trades	$25.09avg.	$240,441.52	−19.9%
Sionna TherapeuticsSION	Open-market sale10b5-1 plan	25/08/26–25/08/28	25/08/28	23,416 sh3 trades	$25.70avg.	$601,857.86	−32.7%
Sionna TherapeuticsSION	Open-market sale10b5-1 plan	25/08/19–25/08/20	25/08/21	52,000 sh2 trades	$21.62avg.	$1,124,335	−42.1%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/06/11	25/06/11	4,500 sh	$50.00	$225,000	−100.0%
Kymera TherapeuticsKYMR	Open-market sale10b5-1 plan	25/06/03	25/06/03	12,000 sh2 trades	$46.10avg.	$553,200	−100.0%